Medivation
Medivation was an American biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation was headquartered in San Francisco, California, beginning operations in December 2004 with the acquisition of Medivation Neurology, Inc. Its final CEO was David Hung. Pfizer announced it would acquire the company in August 2016, and completed the acquisition in October 2016.
Link from a Wikipage to another Wikipage
primaryTopic
Medivation
Medivation was an American biopharmaceutical company focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation was headquartered in San Francisco, California, beginning operations in December 2004 with the acquisition of Medivation Neurology, Inc. Its final CEO was David Hung. Pfizer announced it would acquire the company in August 2016, and completed the acquisition in October 2016.
has abstract
Medivation was an American bio ...... e acquisition in October 2016.
@en
founding year
industry
key person
owner
owning company
Link from a Wikipage to an external page
Wikipage page ID
37,668,566
page length (characters) of wiki page
Wikipage revision ID
1,022,424,420
Link from a Wikipage to another Wikipage
foundation
industry
key people
location city
San Francisco, California
@en
location country
United States
@en
logo
@en
name
Medivation, Inc.
@en
owner
wikiPageUsesTemplate
subject
hypernym
comment
Medivation was an American bio ...... e acquisition in October 2016.
@en
label
Medivation
@en
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
Medivation, Inc.
@en